Semi-annual Report for 2026
Filed with SSE · · 194 pages · Chinese
Harbin Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Harbin Pharmaceutical
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on the Proposed Selection in the 12th Batch of National Centralized Drug Procurement
- Announcement on the Affiliated Enterprise's Receipt of the Approval Notice for the Marketing Application of a Chemical API
- Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk Warning
- Announcement on Resolutions of the 27th Meeting of the 10th Board of Directors
Later from Harbin Pharmaceutical
- Announcement on Imposition of Detention Measures on a Director and Senior Executive
- (600664)"Harbin Pharmaceutical Group Co., Ltd."Announcement on Amendment to the Articles of Association
- (600664)"Harbin Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 29th Meeting of the 10th Board of Directors
- (600664)"Harbin Pharmaceutical Group Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
- (600664)"Harbin Pharmaceutical Group Co., Ltd."Report for Q3 2026
Follow Harbin Pharmaceutical into a list and get an email when it puts out news.
Follow Harbin Pharmaceutical